Source-based interaction record

Enantyum 25 mg + Tenofovir disoproxil fumarate

Enantyum 25 mg + Tenofovir disoproxil fumarate: published drug interaction record, medicine facts and reference links. Generic / active ingredient: Deksketoprofen Trometamol + tenofovir disoproxil fumarate.

Free preview

Essential record information

Public access

Free record overview for Enantyum 25 mg + Tenofovir disoproxil fumarate. Review the medicine identities and available reference links below; detailed interaction information is in the access section.

Enantyum 25 mg (Turkish record)

Active ingredient / generic name: Deksketoprofen Trometamol
ATC code: M01AE17

Tenofovir disoproxil fumarate

Active ingredient / generic name: tenofovir disoproxil fumarate
ATC code: J05AF07
Administration route: Oral

Record type: Published interaction record
Source record version: SPL v31; effective 2025-02-18; posted 2025-02-24; checked 2026-11-04

Record sources

DailyMed: Viread (tenofovir disoproxil fumarate), Gilead prescribing information (opens in a new tab)

Source checked: 2026-11-04

A source check is not an independent clinical review.

Access to this record

Free preview: Medicine identities, available source links and, where available, selected low-level related interaction records.
Paid details: The selected pair’s available detailed interaction explanation, mechanism and clinical context require access to this record.

A single-page purchase unlocks this resource only. Membership provides the page allowance shown in your plan; it does not unlock every related record automatically.

This page only: 6.00 USD One-time payment
Monthly membership: 40.00 USD / month · starting price

A verified account is required. Monthly membership renews automatically with no trial period. Taxes and the final total appear in checkout.

Examples selected from real records

Selected free interaction examples

Free

These examples concern other medicine pairs involving the medicines above. They do not assess the main pair on this page.

Published related records: 165. The selection below does not represent the complete list.

Informational

Raltegravir + Tenofovir disoproxil fumarate

Recorded classification; this selection is not a full list or a conclusion that use is safe.

dailymed.nlm.nih.gov Source checked: 2026-11-04

View record

Informational

Maraviroc + Tenofovir disoproxil fumarate

Recorded classification; this selection is not a full list or a conclusion that use is safe.

dailymed.nlm.nih.gov Source checked: 2026-11-04

View record

Informational

Emtricitabine + Tenofovir disoproxil fumarate

Recorded classification; this selection is not a full list or a conclusion that use is safe.

dailymed.nlm.nih.gov Source checked: 2026-11-04

View record

Important information and detailed context

Unlock important interaction details

The basic information is available above. Details such as explanations of moderate or severe interaction records, mechanisms and clinical context are available through paid access to the relevant record or your membership allowance.

The related record group also includes interactions classified as moderate or severe. Each record’s access right applies to its own details.

Interaction level and explanation
Interaction mechanism
Clinical context and precautions

This page only

6.00 USDOne-time payment

Permanent access to the selected resource. No subscription required.

Buy access to this page

Monthly membership

40.00 USD/ month · starting price

A monthly page allowance for your plan. Revisit pages unlocked during the same billing period.

Explore memberships

Monthly memberships renew automatically; there is no trial period. Taxes and the final total appear in checkout.

A verified account is required. Turkish and English versions of the same resource share one access right.

This information is not personal treatment advice. Discuss treatment decisions with your doctor or pharmacist.